---
title: "Medical Weight Loss with GLP-1 | PBTEW"
url: "https://pbtew.com/blog/medical-weight-loss-glp1-guide"
description: "A comprehensive endocrinologist-led guide to GLP-1 receptor agonists (Ozempic, Wegovy, Mounjaro, Zepbound) for medically supervised weight loss, how they…"
lastmod: "2026-06-29"
language: "en"
author: "Dr. Anna Frisch"
published: "2026-06-29"
category: "Diabetes & Metabolism"
---

# Medical Weight Loss with GLP-1: An Endocrinologist's Guide to Semaglutide & Tirzepatide

Medical weight loss has changed dramatically with the arrival of **GLP-1 receptor agonists**, medications like **semaglutide** (Ozempic®, Wegovy®) and **tirzepatide** (Mounjaro®, Zepbound®). At Palm Beach Thyroid & Endocrinology Wellness, we provide endocrinologist-led, medically supervised weight loss programs that go far beyond a prescription.

## What Are GLP-1 Medications?

GLP-1 (glucagon-like peptide-1) receptor agonists mimic a natural gut hormone that regulates appetite, blood sugar, and digestion. Originally developed for type 2 diabetes, they produce significant, sustained weight loss by:

- Slowing gastric emptying so you feel full longer
- Reducing appetite and food cravings via brain signaling
- Improving insulin sensitivity and lowering blood glucose
- Modulating reward pathways tied to overeating

## Semaglutide vs. Tirzepatide: What's the Difference?

**Semaglutide** (Wegovy for weight loss; Ozempic for diabetes) targets the GLP-1 receptor alone. Clinical trials show average weight loss of **~15% of body weight** over 68 weeks.

**Tirzepatide** (Zepbound for weight loss; Mounjaro for diabetes) is a dual GIP/GLP-1 agonist, it activates two metabolic receptors. SURMOUNT trial data shows average weight loss of **~21% of body weight** at the highest dose.

## Who Qualifies for GLP-1 Weight Loss Treatment?

FDA-approved criteria for medical weight loss therapy include:

- BMI ≥ 30, or
- BMI ≥ 27 with at least one weight-related condition (type 2 diabetes, hypertension, dyslipidemia, sleep apnea, PCOS, metabolic syndrome)

An endocrinologist evaluates your full metabolic picture, thyroid function, insulin resistance, hormonal drivers, and contraindications, before prescribing.

## Why Endocrinologist Supervision Matters

GLP-1s are powerful metabolic medications, not lifestyle accessories. Telehealth mills and compounded "research grade" versions skip the medical workup that protects you. Our supervised program includes:

- **Comprehensive metabolic workup**, thyroid panel, fasting insulin, HbA1c, lipid panel, liver/kidney function, vitamin levels
- **Personalized titration** to minimize nausea, GI side effects, and muscle loss
- **Nutrition guidance** to preserve lean mass, protein targets, micronutrient support, and clinical nutraceuticals from VitellaMD®
- **Ongoing monitoring** for gallbladder issues, pancreatitis risk, thyroid concerns, and rebound after stopping
- **Off-ramp planning**, what happens when you stop, and how to maintain results

## What to Expect on Treatment

Most patients start at the lowest dose and titrate up monthly. Common early side effects (nausea, constipation, fatigue) usually subside within weeks. Expect weight loss of 1 to 2 lbs per week on average, with steeper losses early and a plateau around 12 to 18 months.

## Beyond the Shot: Metabolic Wellness

A GLP-1 alone is not a long-term strategy. Our program integrates:

- Resistance training guidance to protect muscle
- Protein-forward nutrition (1.2 to 1.6 g/kg)
- Sleep, stress, and circadian optimization
- Thyroid and sex-hormone evaluation when weight loss stalls
- Targeted VitellaMD® clinical nutraceuticals for metabolic support

## Get Started in Palm Beach

If you've considered GLP-1 weight loss and want true endocrinology-led care, not a pharmacy refill mill, schedule a consultation with Dr. Anna Frisch at Palm Beach Thyroid & Endocrinology Wellness. Call [561-303-2800](tel:+15613032800) or book online.

_This article is educational and not medical advice. GLP-1 medications carry risks including pancreatitis, gallbladder disease, and a boxed warning for medullary thyroid cancer. Always consult a qualified physician._